CDC published new recommendations for use of Japaneseᅠ encephalitis vaccine in children
On Nov. 15, 2013, the Advisory Committee on Immunization Practices (ACIP) voted to extend existing recommendations for use of inactivated Vero cell culture-derived Japanese encephalitis (JE) vaccine (JE-VC) (Ixiaro, Intercell Biomedical) to include children aged 2 months through 16 years.
JE virus, a mosquito-borne flavivirus, is an important cause of encephalitis in Asia. JE is a severe disease with a case fatality rate of 20%–30% and neurologic or psychiatric sequelae in 30%–50% of survivors (4). Although no specific treatment is available, the disease is vaccine-preventable.
Tags:
Source: U.S. Centers for Disease Control and Prevention
Credit: